Pulse Biosciences (PLSE) Net Cash Flow (QoQ) (2015 - 2025)
Pulse Biosciences (PLSE) Net Cash Flow (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.03% |
| Sep 30, 2025 | 13.88% |
| Jun 30, 2025 | -1,141.90% |
| Mar 31, 2025 | -96.82% |
| Dec 31, 2024 | -26.18% |
| Sep 30, 2024 | 708.09% |
| Jun 30, 2024 | 8.34% |
| Mar 31, 2024 | -57.45% |
| Dec 31, 2023 | 27.99% |
| Sep 30, 2023 | -279.85% |
| Jun 30, 2023 | 166.03% |
| Mar 31, 2023 | 12.24% |
| Dec 31, 2022 | -114.76% |
| Sep 30, 2022 | 2,461.92% |
| Jun 30, 2022 | 113.31% |
| Mar 31, 2022 | -19.14% |
| Dec 31, 2021 | -146.13% |
| Sep 30, 2021 | 56.37% |
| Jun 30, 2021 | -126.27% |
| Mar 31, 2021 | 779.29% |